Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Reinisch

Showing results (11-20 of 352) with videos related to

Pageof 36
Sort By:
Journal of Crohn'S & Colitis|August 25, 2012
State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel diseaseWalter Reinisch, Michael Staun, Sunil Bhandari, et al.
Journal of Crohn'S & Colitis|May 15, 2018
Targeting Endothelial Ligands: ICAM-1/alicaforsen, MAdCAM-1Walter Reinisch, Kenneth Hung, Mina Hassan-Zahraee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 3, 2014
Factors associated with poor outcomes in adults with newly diagnosed ulcerative colitisWalter Reinisch, Andrew R Reinink, Peter D R Higgins
Journal of Gastroenterology|February 22, 2016
Fecal calprotectin: its scope and utility in the management of inflammatory bowel diseaseShapur Ikhtaire, Mohammad Sharif Shajib, Walter Reinisch, et al.
Clinical and Translational Gastroenterology|December 12, 2022
Adverse Events Related to SARS-CoV-2 Vaccine in a Nationwide Cohort of Patients With Inflammatory Bowel DiseaseNadim Mahmud, Walter Reinisch, Manthankumar Patel, et al.
Gastroenterology|February 10, 2026
Toward Integration of Molecular Measures and Artificial Intelligence-Based Assessments With Clinical End Points in Inflammatory Bowel DiseaseWalter Reinisch, Jens Rittscher, Marietta Iacucci, et al.
Alimentary Pharmacology & Therapeutics|January 16, 2023
Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel diseaseNabeel Khan, Nadim Mahmud, Manthankumar Patel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 16, 2022
Induction Efficacy of Upadacitinib in Therapy-Refractory Crohn's Disease: A Retrospective Case SeriesJagoda Pokryszka, Sieglinde Reinisch, Christian Primas, et al.
Shock (Augusta, Ga.)|July 18, 2013
Monocyte human leukocyte antigen-DR expression-a tool to distinguish intestinal bacterial infections from inflammatory bowel disease?Wolfgang Tillinger, Ruth Jilch, Thomas Waldhoer, et al.
British Journal of Clinical Pharmacology|January 24, 2015
A pharmacokinetic comparison of anrukinzumab, an anti- IL-13 monoclonal antibody, among healthy volunteers, asthma and ulcerative colitis patientsFei Hua, Jakob Ribbing, Walter Reinisch, et al.
Pageof 36

Showing results (11-20 of 352) with videos related to

Sort By:
Pageof 36
Journal of Crohn'S & Colitis|August 25, 2012
State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel diseaseWalter Reinisch, Michael Staun, Sunil Bhandari, et al.
Journal of Crohn'S & Colitis|May 15, 2018
Targeting Endothelial Ligands: ICAM-1/alicaforsen, MAdCAM-1Walter Reinisch, Kenneth Hung, Mina Hassan-Zahraee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 3, 2014
Factors associated with poor outcomes in adults with newly diagnosed ulcerative colitisWalter Reinisch, Andrew R Reinink, Peter D R Higgins
Journal of Gastroenterology|February 22, 2016
Fecal calprotectin: its scope and utility in the management of inflammatory bowel diseaseShapur Ikhtaire, Mohammad Sharif Shajib, Walter Reinisch, et al.
Clinical and Translational Gastroenterology|December 12, 2022
Adverse Events Related to SARS-CoV-2 Vaccine in a Nationwide Cohort of Patients With Inflammatory Bowel DiseaseNadim Mahmud, Walter Reinisch, Manthankumar Patel, et al.
Gastroenterology|February 10, 2026
Toward Integration of Molecular Measures and Artificial Intelligence-Based Assessments With Clinical End Points in Inflammatory Bowel DiseaseWalter Reinisch, Jens Rittscher, Marietta Iacucci, et al.
Alimentary Pharmacology & Therapeutics|January 16, 2023
Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel diseaseNabeel Khan, Nadim Mahmud, Manthankumar Patel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 16, 2022
Induction Efficacy of Upadacitinib in Therapy-Refractory Crohn's Disease: A Retrospective Case SeriesJagoda Pokryszka, Sieglinde Reinisch, Christian Primas, et al.
Shock (Augusta, Ga.)|July 18, 2013
Monocyte human leukocyte antigen-DR expression-a tool to distinguish intestinal bacterial infections from inflammatory bowel disease?Wolfgang Tillinger, Ruth Jilch, Thomas Waldhoer, et al.
British Journal of Clinical Pharmacology|January 24, 2015
A pharmacokinetic comparison of anrukinzumab, an anti- IL-13 monoclonal antibody, among healthy volunteers, asthma and ulcerative colitis patientsFei Hua, Jakob Ribbing, Walter Reinisch, et al.
Pageof 36